Fibrinolysis in normal plasma and blood: evidence for significant mechanisms independent of the plasminogen-plasmin system
Authors:
- LA MorozLMLA Moroz
- Nj GilmoreNGNj Gilmore
Open Access
- 1 October 1976
- journal article
- Published by American Society of Hematology in Blood
- Vol. 48 (4) , 531-545
Abstract
Fibrinolytic activity of normal plasma and blood has been measured by 125l-fibrin solid phase assay. Activity of plasma is not affected by removal of plasminogenplasmin by affinity chromatography. Activities of euglobulin and pseudoglobulin fractions are approximately equal. epsilon-aminocaproic acid (EACA) (10 mM), tranexamic acid (10 mM), diisopropylfluorophosphate (DFP, 50 mM), and soybean and lima bean trypsin inhibitors (100 mug/ml) do not inhibit plasma activity at concentrations that inhibit pure plasmin and urokinase-activated plasma. Activity is not affected by glass contact and is not inhibited by inhibitors of contact or enzymatic activation of Hageman factor (hexadimethrine bromide, 100 mug/ml; cytochrome C, 250 mug/ml; spermidine, 2 mM; phenylmethylsulfonylfluoride, 1 mM). It is inhibited partially (30%-40%) by heating (56 degrees C, 30 min) and by zymosan (2.5 mg/ml; 40%-90% inhibition), and is increased by hydrazine (20 mM), salicylaldoxime (20 mM), DFP (50 mM), and tosyl-L-arginine methyl ester (TAMe, 10 mM)-the latter two at concentrations known to inhibit Cls of the classic, and factor D of the alternate complement pathways. Increase fibrinolytic activity with TAMe is associated with reciprocal decrease in classic and alternate complement pathway activity. It is concluded that normal plasma fibrinolytic activity is relatively independent of plasmin as the ultimate fibrinolytic enzyme, that Hageman factor-dependent pathways are of minor importance, and that significant heat-stable and heat-labile nonplasmin fibrinolytic activities are operative. These may include proteinases involved in complement activation, and in common control of classic and alternate complement pathways, as well as other nonplasmin proteinases.Keywords
This publication has 12 references indexed in Scilit:
- An alternative pathway for fibrinolysis. I. The cleavage of fibrinogen by leukocyte proteases at physiologic pH.Journal of Clinical Investigation, 1975
- INHIBITION OF COMPLEMENT-DERIVED ENZYMESAnnals of the New York Academy of Sciences, 1975
- Activation of the Alternate Pathway of Human Complement by Rabbit CellsThe Journal of Immunology, 1974
- ACTIVATION OF HAGEMAN FACTOR IN SOLID AND FLUID PHASESJournal of Experimental Medicine, 1973
- Lysosomal Enzyme Release from Human Leukocytes: Mediation by the Alternate Pathway of Complement ActivationThe Journal of Immunology, 1973
- Plasma Inhibitors of the Components of the Fibrinolytic Pathway in ManJournal of Clinical Investigation, 1973
- THE FIBRINOLYTIC PATHWAY OF HUMAN PLASMAJournal of Experimental Medicine, 1972
- Plasminogen: Purification from Human Plasma by Affinity ChromatographyScience, 1970
- STUDIES ON ENHANCED FIBRINOLYTIC ACTIVITY IN MAN*Journal of Clinical Investigation, 1959
- The Fibrinolytic Activity of Normal BloodBritish Journal of Haematology, 1955